BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24614826)

  • 1. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
    Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
    Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear morphometry as an adjunct to cytopathologic examination of endometrial brushings on LBC samples: A prospective approach to combined evaluation in endometrial neoplasms and look alikes.
    Norimatsu Y; Irino S; Maeda Y; Yanoh K; Kurokawa T; Hirai Y; Kobayashi TK; Fulciniti F
    Cytopathology; 2021 Jan; 32(1):65-74. PubMed ID: 32794283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of DJ-1 in endometrial cancer: close correlation with clinicopathological features and apoptosis.
    Shu K; Xiao Z; Long S; Yan J; Yu X; Zhu Q; Mei T
    Int J Gynecol Cancer; 2013 Jul; 23(6):1029-35. PubMed ID: 23727824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.
    Mhawech-Fauceglia P; Yan L; Liu S; Pejovic T
    Histopathology; 2013 Jun; 62(7):976-85. PubMed ID: 23570281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
    Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammaglobin B expression in human endometrial cancer.
    Tassi RA; Bignotti E; Falchetti M; Calza S; Ravaggi A; Rossi E; Martinelli F; Bandiera E; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2008; 18(5):1090-6. PubMed ID: 18021217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
    Shaco-Levy R; Sharabi S; Piura B; Sion-Vardy N
    Acta Obstet Gynecol Scand; 2008; 87(8):868-74. PubMed ID: 18607832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Profiling of Endometrial Serous Carcinoma.
    Chen W; Husain A; Nelson GS; Rambau PF; Liu S; Lee CH; Lee S; Duggan MA; Köbel M
    Int J Gynecol Pathol; 2017 Mar; 36(2):128-139. PubMed ID: 27167671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
    Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
    Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
    Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
    BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
    Song H; Li C; Lu R; Zhang Y; Geng J
    Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.
    Fridrichova I; Kalinkova L; Karhanek M; Smolkova B; Machalekova K; Wachsmannova L; Nikolaieva N; Kajo K
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
    Wu HW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
    [No Abstract]   [Full Text] [Related]  

  • 15. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.
    Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S
    Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D; Huang HJ; He CN; Wang KY
    Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma.
    Haley SL; Malhotra RK; Qiu S; Eltorky ME
    Ann Diagn Pathol; 2011 Dec; 15(6):402-6. PubMed ID: 21855381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.
    Zhang D; Lim SG; Koay ES
    Int J Oncol; 2007 Sep; 31(3):577-84. PubMed ID: 17671684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.